# ZAN

## Relevance tier by entity

|Entity|Tier|Description                           |
|:------:|:----:|--------------------------------------|
|BL    |2   |relevance in BL not firmly established|

## Mutation incidence in large patient cohorts (GAMBL reanalysis)

|Entity|source               |frequency (%)|
|:------:|:---------------------:|:-------------:|
|BL    |GAMBL genomes+capture|5.77         |
|BL    |Thomas cohort        |  NA         |
|BL    |Panea cohort         |  NA         |

## Mutation pattern and selective pressure estimates

|


> [!NOTE]
> First described in BL in 2022 by [Burkhardt B](https://pubmed.ncbi.nlm.nih.gov/35794096)


View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/ZAN_protein.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/ZAN_protein_hg38.html)

![image](images/proteinpaint/ZAN_NM_003386.svg)

View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/ZAN.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/ZAN_hg38.html)

![image](images/proteinpaint/ZAN.svg)
## ZAN Expression
![image](images/gene_expression/ZAN_by_pathology.svg)
<!-- ORIGIN: burkhardtClinicalRelevanceMolecular2022b -->
